AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04666987 — intervention group
Intervention type: DRUG
Intervention: Insulin degludec and liraglutide (IDegLira)
Description: Paricipants will be treated with commercially available Xultophy® according to routine clinical practice at the discretion of the treating physician, following approved label in Italy. The decision to initiate treatment with commercially available Xultophy® has been made by the patient and the treating physician before and independently from the decision to participate in this study.
Study NCT01268631 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Duloxetine
Description: Initial dose of 30 mg/d will be given for one week, in order to minimize possible side effects and drop outs, and then a fixed dose of 60 mg/d will be given for additional 4 weeks. The assessing person will contact patients by phone every week during the treatment period to receive the pain score for the last 24 hours, so we will have an indication of the effect among patients will discontinue medication. Patients will be asked to visit the clinic during the last week of treatment, for assessment of clinical pain (questionnaires) and pain modulation.
Study NCT01268631 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pregabalin
Description: Initial dose of 75x2mg/d for one week, and then fixed dose of 150x2mg/d for the following 4 weeks. Drug should not be taken with meals. Same protocol will be applied as for Duloxetine.
Study NCT02101944 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carfilzomib
Description: Given IV
Study NCT02101944 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Given IV
Study NCT02101944 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies
Study NCT02101944 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pelareorep
Description: Given IV
Study NCT01591096 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tissue plasminogen activator (Activase®)
Description: Investigation labeled tPA will be obtained for all sites by the Core Pharmacy as commercially available recombinant tPA (Genentech as Activase®) for IV administration. The Bayesian method of toxicity probability intervals will be used to select one of the following three dose tiers (0.75, 0.9, 1.0 mg/kg) of IV tPA. The dose escalation for the two age groups (2-10, 11-17 years) will be performed independently. The maximum dose for each tier will be reached at a weight of 90 kg.
Study NCT02473172 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pressure Support ventilation
Description: Assisted mechanical ventilation
Study NCT02473172 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Neurally Adjusted Ventilatory Assist
Description: Assisted mechanical ventilation
Study NCT01467713 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ramelteon SL
Description: Ramelteon sublingual (SL) tablets
Study NCT01467713 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Ramelteon sublingual (SL) placebo-matching tablets
Study NCT02661880 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: preferred music
Description: listening to preferred music choices
Study NCT03125252 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Bundle
Description: Awakening and Breathing Coordination Delirium monitoring and management (detection and management of delirium) Early mobility~Factors of environment:~* thirst~* noise~* pain and well-being~* sleep~* isolation
Study NCT03125252 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Standard Paramedical and Medical practices
Description: The current recommendations recommend the following scheme:~* Identification and correction of an organic cause / factors (sepsis, metabolic disorders, withdrawal syndrome, pain)~* Use of non-pharmacological means (early mobilization, correction of sensory deficits, temporo-spatial reorientation strategies)~* Use of reference antipsychotic pharmacological means
Study NCT03468517 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Bathe method:
Description: BATHE technique, on the other hand, is one of the short therapeutic consultation techniques that strengthen the doctor-patient relationship. BATHE stands for the initials of the questions that include the titles for Background, Affect, Trouble, Handling and Empathy. It allows evaluating the physiological stress of the patients quickly. BATHE method necessitates an empathetic expression that includes the view of the patient in addition to asking the key questions by the doctor doing the interview
Study NCT01862718 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Thermal Ablation
Description: On Thursday in the first week, subject will receive the radiofrequency ablation.
Study NCT00998920 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: S-equol
Description: oral, BID, 14 days
Study NCT00998920 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: oral, BID, 14 days
Study NCT05368818 — intervention group
Intervention type: OTHER
Intervention: Secukinumab
Description: Included patients treated with Cosentyx (Secukinumab) in a retrospective analysis of the BADBIR data source
Study NCT03836690 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CD62L- Tem
Description: Donor memory T cells that have been depleted of CD62L+
Study NCT03867734 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aztreonam
Description: 2g IM Aztreonam
Study NCT01286259 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Disulfiram
Description: Open label 500mg disulfiram per day by mouth for 14 days
Study NCT00688805 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Propranolol
Description: 40 mg given as a single oral administration in an opaque capsule
Study NCT00688805 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: matching capsule containing no active medication
Study NCT03839238 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: hESC derived MSC like cell
Description: Different dosage of hESC derived MSC like cell for the meniscus injured patients
Study NCT02221115 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Google Glass
Description: The device is a wearable, voice-controlled Android device that resembles a pair of eyeglasses and displays information directly in the user's field of vision
Study NCT02855905 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise/Rest and cold/neutral temperature
Description: Subjects were either exercising or resting in either cold or neutral environmental temperature
Study NCT03467659 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cracked whole wheat porridge
Description: Large particle whole wheat porridge was tested for gastric emptying rate, glycemic response and appetitive response.
Study NCT03467659 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Semolina wheat porridge
Description: Large particle refined wheat porridge was tested for gastric emptying rate, glycemic response and appetitive response.
Study NCT03467659 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Whole wheat flour porridge
Description: Small particle whole wheat porridge was tested for gastric emptying rate, glycemic response and appetitive response.
Study NCT03467659 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Refined wheat flour porridge
Description: Small particle refined wheat porridge was tested for gastric emptying rate, glycemic response and appetitive response.
Study NCT03467659 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Refined wheat flour porridge,fine bran
Description: Small particle refined wheat porridge with small particle bran was tested for gastric emptying rate, glycemic response and appetitive response.
Study NCT03467659 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Refined wheat flour porridge,coarse bran
Description: Small particle refined wheat porridge with large particle bran was tested for gastric emptying rate, glycemic response and appetitive response.
Study NCT04388982 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: low dosage MSCs-Exos administrated for nasal drip
Description: Dosage：5μg MSCs-Exos,Total volume： 1ml Frequency：Twice a week Duration：12 weeks
Study NCT04388982 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: mild dosage MSCs-Exos administrated for nasal drip
Description: Dosage：10μg MSCs-Exos,Total volume： 1ml Frequency：Twice a week Duration：12 weeks
Study NCT01862718 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Standard External Beam Radiation Therapy
Description: During those 2 weeks, subject will receive radiation on Monday, Wednesday and Friday.
Study NCT03086083 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: EMDR standard protocol
Description: Patient have only one standard EMDR session about a traumatic situation remembered by him.
Study NCT03086083 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: protocol without brain stimulation
Description: Patient have only one standard EMDR session about a traumatic situation remembered by him, however, without the bilateral brain stimulation.
Study NCT03296774 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Healthy Beyond Pregnancy
Description: Web-based intervention grounded in behavioral economics and designed to improve adherence with postpartum care.
Study NCT03296774 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Usual Care
Study NCT04626557 — intervention group
Intervention type: PROCEDURE
Intervention: biopsy
Description: biopsy of the endometrium
Study NCT02953132 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MT-4129
Study NCT02953132 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Study NCT04619069 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: SBRT
Description: SBRT to all sites of metastatic disease as seen on PSMA PET scan
Study NCT04619069 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Hormone therapy
Description: Intermittent Hormone Therapy per physician discretion (Min. 8 months)
Study NCT04619069 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hormone therapy
Description: Intermittent Hormone Therapy per physician discretion (Min. 8 months)
Study NCT02918825 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Olanzapine
Description: Olanzapine
Study NCT02918825 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paliperidone
Description: Paliperidone
Study NCT03840642 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Mirror Me
Description: Mirror Me is a telehealth parent training intervention that teaches parents to promote their child's social imitation during play and daily routines. It uses content from Reciprocal Imitation Training (RIT), an evidence-based NDBI that teaches social imitation within affect-laden playful interactions. Mirror Me presents intervention content in four interactive modules. Program development was guided by the technology acceptance model, media richness theory, and principles of instructional design.
Study NCT03840642 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mirror Me
Description: Mirror Me is a telehealth parent training intervention that teaches parents to promote their child's social imitation during play and daily routines. It uses content from Reciprocal Imitation Training (RIT), an evidence-based NDBI that teaches social imitation within affect-laden playful interactions. Mirror Me presents intervention content in four interactive modules. Program development was guided by the technology acceptance model, media richness theory, and principles of instructional design.
Study NCT03840642 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Remote Coaching
Description: Trained therapists will provide feedback to parents as they use the RIT techniques with their child at home. All sessions will follow a similar format including a discussion of accomplishments and challenges, parent practice with feedback, problem solving, and planning for the next week
Study NCT01653223 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: simvastatin
Description: In short statin group: 20 mg per day, start at 5-7 days before surgery and continue for 7 days.~In long statin group: 20 mg per day, start at 5-7 days before surgery and continue for 6 months.
Study NCT02521831 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Spinal Anesthesia (bupivacaine)
Description: Bupivacaine is an amide-type, long-acting local anesthetic. Brand names include Exparel, Marcaine, and Sensorcaine.
Study NCT02521831 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: General Anesthesia (isoflurane)
Description: Isoflurane is a fluorinated ether with general anesthetic and muscle relaxant effects. Brand names include Forane and Terrell.
Study NCT00695981 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Rotator cuff repair
Description: Rotator cuff repair + physical therapy according to a standardized protocol
Study NCT00695981 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conservative treatment
Description: Physiotherapy according to a standardized protocol
Study NCT04184479 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: LEVAmethod by Bertz et al
Description: Ordinary treatment
Study NCT04184479 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: LEVAmethod by Bertz et al
Description: Ordinary treatment
Study NCT02915588 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: early isometric loading after rotator cuff surgery
Study NCT02915588 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: passive motion after rotator cuff surgery
Study NCT00716586 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 2% dorzolamide
Description: Carbonic anhydrase inhibitor, Trusopt (2% dorzolamide)
Study NCT04064437 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Clinical tests
Description: The investigators perform the following clinical tests: vibration threshold test, monofilament test, and height, weight and waist circumference measurement in every participant.
Study NCT04064437 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Clinical tests
Description: The investigators perform the following clinical tests: height, weight and waist circumference measurement in every participant.
Study NCT04064437 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Biochemical tests
Description: The investigators perform blood and urine tests in every participant.
Study NCT04064437 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: DXA scan
Description: The investigators perform a dual energy x-ray absorptiometry (DXA scan or osteodensitometry) in every participant.
Study NCT04064437 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: AGE Reader
Description: The investigators perform a skin advanced glycation end products (AGEs) measurement with the AGE Reader machine in every participant.
Study NCT03151785 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Face-to-face BLS training
Description: Pupils will receive CPR training by standardised face-to-face BLS training only
Study NCT03151785 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Lifesaver training
Description: Pupils will receive CPR training by Lifesaver programme only
Study NCT03151785 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Lifesaver and Face-to-Face BLS training
Description: Pupils will receive CPR training by Lifesaver and standardised face-to-face BLS training
Study NCT04152252 — intervention group
Intervention type: OTHER
Intervention: Real time feedback
Description: Real-time feedback on chest compression depth, chest compression rate and recoil available to EMS while performing CPR. Feedback is delivered as visual text, numeric and graphical presentations on the defibrillator with audio tones for rate.
Study NCT04152252 — intervention group
Intervention type: BEHAVIORAL
Intervention: Post-event debriefing
Description: Structured oral post-event debriefing based on objective performance data from the resuscitation attempt. The debriefing is conducted as hot/immediate self-directed debriefing session with a maximum length of 10 minutes.
Study NCT04366778 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: TEM-tPA
Description: 325 patients with Covid-19 hospitalized in Lyon University Hospitals will have TEM-tPA measurements in parallel to D-dimers every 3 days during the hospitalization period. TEM-tPA of patients with and without thrombosis will be compared and their fibrinolysis (PAI-1, TAFI, tPA, thrombin) will be further explored.
Study NCT05243498 — intervention group
Intervention type: OTHER
Intervention: Assessment of the optimised Allogenomic Mismatch Score (AMS)
Description: Optimised Allogenomic Mismatch Score (AMS) is a continuous variable based on the number of nsSNP between the donor and the recipient, encountering only peptides that can be presented by the donors' MHC (using another layer of algorithm, NetMHCpan).
Study NCT00935129 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: OmniPod system
Description: Patients will be treated with the OmniPod system for 12 weeks
Study NCT00935129 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Patient's conventional pump
Description: patients will be treated with their conventional pump for 12 weeks
Study NCT00653419 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: buspirone HCl
Description: Tablets, 30 mg, single-dose
Study NCT00653419 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Buspar
Description: Tablets, 30 mg, single-dose
Study NCT00967915 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Frentomy
Description: Frenotomy will be performed. This procedure involves crushing frenulum tissue with straight hemostat for hemostasis and anesthesia while tongue is elevated with elevator. Frenulum then cut to desired length with iris scissors. Patient then returned to parents and immediately breastfeeds without parent observing infant's mouth.
Study NCT00967915 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham procedure
Description: Infant taken into room away from parents and no frenotomy performed. Infant's mouth is examined but no interventions made.
Study NCT01651650 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Inhalation through Chiesi NEXThaler DPI
Description: Inhalatory manoeuvre through Chiesi NEXThaler DPI repeated at least twice in order to have two evaluable data set
Study NCT03992599 — intervention group
Intervention type: PROCEDURE
Intervention: Laparoscopic modified complete mesocolic excision
Description: First, complete kocherization may be required to clear possible tumor spread if the tumor is infiltrating or adhering to the duodenum or perinephric fat tissue. Second, if the tumor is locally advanced, the entire prerenal soft tissue behind Gerota's fascia may need to be cleared, especially for tumors growing toward the posterior. The third difference of mCME with the conventional CME involves the tailored resection of the mesocolon and ileal mesentery according to tumor location. After identifying the root of the middle colic artery, the site of the vascular ligation depends on the location of the tumor. When the tumor is located in the cecum and ascending colon, only the right branch of the middle colic artery is ligated. If the tumor was present in these latter sites, the root of the middle colic artery is ligated.
Study NCT01064180 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carvedilol
Description: Carvedilol Tablets 25 mg
Study NCT03944707 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LOU064 100 mg
Description: LOU064 100 mg once daily orally administered as two 50 mg capsules
Study NCT04388982 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: high dosage MSCs-Exos administrated for nasal drip
Description: Dosage：20μg MSCs-Exos,Total volume： 1ml Frequency：Twice a week Duration：12 weeks
Study NCT02282501 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: enteral feeding by nasogastric tube.
Description: method of administration enteral feeding by nasogastric tube.
Study NCT03944707 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo once daily administered orally as capsules
Study NCT01545752 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: teaching by non-interactive CD
Description: teaching book with non-interactive CD
Study NCT01064180 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carvedilol
Description: Carvedilol Tablets 25 mg
Study NCT01278511 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Canadian C-Spine rule
Description: Emergency medicine undergraduates will accompany prehospital emergency crews and apply the Canadian C-Spine rule, though cervical collar will be applicated per current protocol.
Study NCT03481725 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ACTIVE peripheral nerve stimulation with a percutaneously inserted lead and wearable stimulator (SPR Therapeutics, Cleveland, Ohio)
Description: ACTIVE peripheral nerve stimulation with a percutaneously inserted lead and wearable stimulator (SPR Therapeutics, Cleveland, Ohio) that generates electric current for 14 days
Study NCT01545752 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Interactive CD
Description: Teaching book with interactive CD
Study NCT00725725 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy
Description: Participants underwent 5 weekly CBT session (sessions were 60-90 minutes in duration).